X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxyntomodulin (274) 274
animals (212) 212
humans (150) 150
index medicus (134) 134
glucagon-like peptide-1 (122) 122
male (120) 120
endocrinology & metabolism (108) 108
glucagon (108) 108
rats (91) 91
obesity (74) 74
glp-1 (57) 57
mice (57) 57
peptides (56) 56
appetite (50) 50
food-intake (47) 47
glucagon-like peptide 1 (47) 47
proglucagon (47) 47
glucagon-like peptides - pharmacology (46) 46
amino acid sequence (45) 45
glucose (43) 43
body-weight (42) 42
ghrelin (41) 41
glicentin (40) 40
female (39) 39
glucagon - metabolism (38) 38
insulin (38) 38
glucagon - pharmacology (37) 37
glucagon-like peptide-1 receptor (37) 37
oxyntomodulin - pharmacology (37) 37
peptide yy (37) 37
biochemistry & molecular biology (36) 36
eating - drug effects (36) 36
obesity - drug therapy (34) 34
peptide fragments - pharmacology (34) 34
physiology (34) 34
hormones (32) 32
pharmacology & pharmacy (31) 31
research (31) 31
gastroenterology & hepatology (30) 30
molecular sequence data (30) 30
cholecystokinin (29) 29
diabetes (29) 29
glucagon-like peptide 1 - metabolism (29) 29
rat (29) 29
enteroglucagon (28) 28
rats, wistar (28) 28
adult (27) 27
gut hormones (27) 27
oxyntomodulin - metabolism (27) 27
reduces food-intake (26) 26
body weight (24) 24
body-weight gain (24) 24
food intake (24) 24
peptides - pharmacology (24) 24
physiological aspects (24) 24
radioimmunoassay (24) 24
receptors, glucagon - metabolism (24) 24
dextrose (23) 23
mice, inbred c57bl (23) 23
obesity - metabolism (23) 23
digestive, oral, and skin physiology (22) 22
dose-response relationship, drug (22) 22
inhibits food-intake (22) 22
type 2 diabetes (22) 22
analysis (21) 21
glucagon-like peptides - metabolism (21) 21
insulin - metabolism (21) 21
middle aged (20) 20
pancreas (20) 20
plasma ghrelin levels (20) 20
receptor (20) 20
bioactive enteroglucagon oxyntomodulin (19) 19
glucagon-like peptides - blood (19) 19
peptide yy - metabolism (19) 19
pyy (19) 19
rodents (19) 19
appetite regulation - physiology (18) 18
bioactive enteroglucagon (18) 18
chromatography, high pressure liquid (18) 18
eating - physiology (18) 18
expression (18) 18
gastrointestinal hormones - physiology (18) 18
obesity - physiopathology (18) 18
peptide-yy (18) 18
receptors, glucagon - agonists (18) 18
secretion (18) 18
somatostatin (18) 18
glucagon-37 (17) 17
insulin secretion (17) 17
oxyntomodulin - therapeutic use (17) 17
pancreatic polypeptide (17) 17
peptide fragments - metabolism (17) 17
protein precursors - metabolism (17) 17
body weight - drug effects (16) 16
c-terminal octapeptide (16) 16
cell line (16) 16
gastric-acid secretion (16) 16
gastrointestinal hormones - pharmacology (16) 16
glucagon-like peptide 1 - pharmacology (16) 16
insulin - blood (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
eLife, ISSN 2050-084X, 03/2015, Volume 2015, Issue 4, p. e06253
Journal Article
Diabetes, ISSN 0012-1797, 10/2009, Volume 58, Issue 10, pp. 2258 - 2266
Journal Article
Diabetes, ISSN 0012-1797, 06/2018, Volume 67, Issue 6, pp. 1105 - 1112
Oxyntomodulin (OXM), an enteroendocrine hormone, causes appetite suppression, increased energy expenditure, and weight loss in obese humans via activation of... 
TRIAL | GLP-1 | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE | INSULIN-SECRETION | ENDOCRINOLOGY & METABOLISM | BETA-CELL SENSITIVITY | INFUSION | Overweight - complications | Oxyntomodulin - administration & dosage | Obesity - drug therapy | Overweight - drug therapy | Humans | Anti-Obesity Agents - adverse effects | Male | Insulin - blood | Obesity - blood | Anti-Obesity Agents - therapeutic use | Glucose - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Glucagon-Like Peptide-1 Receptor - metabolism | Insulin-Secreting Cells - metabolism | Hyperglycemia - chemically induced | Hypoglycemic Agents - administration & dosage | Adult | Insulin Secretion | Diabetes Mellitus, Type 2 - complications | Body Mass Index | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Glucose - adverse effects | Hyperglycemia - prevention & control | Anti-Obesity Agents - administration & dosage | Double-Blind Method | Obesity - complications | Receptors, Glucagon - metabolism | Oxyntomodulin - adverse effects | Oxyntomodulin - therapeutic use | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Insulin-Secreting Cells - drug effects | Overweight - blood | Infusions, Intravenous | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Cohort Studies | Type 2 diabetes | Overweight persons | Care and treatment | Weight loss | Research | Oxyntomodulin | Health aspects | Risk factors
Journal Article
Journal of Peptide Science, ISSN 1075-2617, 04/2011, Volume 17, Issue 4, pp. 270 - 280
Journal Article
Journal Article